SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-020728
Filing Date
2020-07-30
Accepted
2020-07-30 08:22:41
Documents
2
Period of Report
2020-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8454
2 EX-24 DOCUMENT attachment1.htm EX-24 3635
  Complete submission text file 0000899243-20-020728.txt   13575
Mailing Address C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Hallal David (Reporting) CIK: 0001457477 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39409 | Film No.: 201059320

Mailing Address 2925 RICHMOND AVE. SUITE 1274 HOUSTON TX 77098
Business Address 2925 RICHMOND AVE. SUITE 1274 HOUSTON TX 77098 651-628-9259
Allovir, Inc. (Issuer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)